The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

DSE:IBNSINA Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	9,126	9,189	7,805	8,954	9,270	7,708
Market Cap Growth	-19.51%	17.73%	-12.84%	-3.40%	20.27%	10.08%
Enterprise Value	10,604	10,667	8,919	9,692	9,892	8,398
Last Close Price	292.10	287.80	239.44	268.97	272.99	223.17
PE Ratio	14.41	14.51	11.64	14.79	15.30	15.76
PS Ratio	0.77	0.77	0.69	0.98	1.09	1.05
PB Ratio	2.28	2.30	2.21	2.93	3.53	3.59
P/TBV Ratio	2.32	2.34	2.23	2.96	3.56	3.59
P/FCF Ratio	-	-	-	18.93	173.59	24.89
P/OCF Ratio	12.61	12.70	17.78	9.97	22.15	13.96
EV/Sales Ratio	0.89	0.90	0.78	1.06	1.17	1.14
EV/EBITDA Ratio	9.53	9.59	5.09	6.22	9.69	9.11
EV/EBIT Ratio	11.75	11.82	9.75	11.82	12.05	11.46
EV/FCF Ratio	-41.13	-	-	20.49	185.25	27.12
Debt / Equity Ratio	0.52	0.52	0.53	0.32	0.41	0.40
Debt / EBITDA Ratio	1.86	1.86	1.06	0.62	1.02	0.91
Debt / FCF Ratio	-	-	-	2.09	20.02	2.80
Asset Turnover	1.69	1.69	1.98	1.96	2.08	2.03
Inventory Turnover	4.18	4.18	4.99	4.86	5.49	6.00
Quick Ratio	0.21	0.21	0.25	0.23	0.35	0.27
Current Ratio	1.15	1.15	1.13	1.26	1.46	1.26
Return on Equity (ROE)	16.82%	16.82%	20.38%	21.33%	25.37%	24.91%
Return on Assets (ROA)	8.02%	8.02%	9.93%	11.00%	12.59%	12.58%
Return on Capital (ROIC)	9.82%	9.82%	12.08%	13.24%	15.30%	15.90%
Return on Capital Employed (ROCE)	17.80%	17.80%	21.80%	23.10%	25.80%	27.20%
Earnings Yield	6.94%	6.89%	8.59%	6.76%	6.54%	6.35%
FCF Yield	-2.83%	-2.81%	-2.24%	5.28%	0.58%	4.02%
Dividend Yield	2.16%	-	2.63%	2.23%	2.20%	2.11%
Payout Ratio	30.62%	30.62%	26.83%	29.49%	29.28%	26.89%
Total Shareholder Return	2.15%	-	2.63%	2.23%	2.20%	2.11%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.